The Use of Ultra-Long-Acting Insulin Analogue Degludec in Type 1 Diabetes Mellitus in Clinical Practice: The Influence on Quality of Life and Satisfaction With Treatment

Almanac of Clinical Medicine
doi 10.18786/2072-0505-2016-44-4-392-405
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Moscow Regional Research and Clinical Institute (MONIKI)

Related search

Effect of Switching Basal Insulin Regimen to Degludec on Quality of Life in Japanese Patients With Type 1 and Type 2 Diabetes Mellitus

Journal of Pharmaceutical Health Care and Sciences
2015English

Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-Long-Acting Basal Insulin

Pharmaceutical Research
Organic ChemistryBiotechnologyMolecular MedicinePharmacologyPharmaceutical Science
2012English

Cost Analysis of Insulin Degludec in Comparison With Insulin Glargine U100 in the Treatment of Type 1 Diabetes Mellitus in the Brazilian Private Health Care System

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Clinical and Cost Implications of Insulin Degludec in Patients With Type 1 Diabetes and Problematic Hypoglycemia: A Quality Improvement Project

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

A Survey of Physician Experience and Treatment Satisfaction Using Fast-Acting Insulin Aspart in People With Type 1 or Type 2 Diabetes

Postgraduate Medicine
Medicine
2020English

Cost-Effectiveness of Insulin Degludec Compared With Insulin Glargine for Patients With Type 2 Diabetes Mellitus Initiating Insulin Therapy in the United Kingdom

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

The Relationship of Depression to Treatment Adherence, Quality of Life and Health Outcomes in Type 1 Diabetes Mellitus

E-Journal of Applied Psychology
2006English

Health-Related Quality of Life, Treatment Satisfaction, and Costs Associated With Intraperitoneal Versus Subcutaneous Insulin Administration in Type 1 Diabetes: A Randomized Controlled Trial

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2010English

Use of Fast‐acting Insulin Aspart in Insulin Pump Therapy in Clinical Practice

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy